Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:c-cell hyperplasia'
(id=6989489 ; fe=en:c-cell hyperplasia ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=15568 creation date=2017-06-25 touchdate=2025-12-17 23:29:09.000)
≈ 253 relations sortantes

  1. en:c-cell hyperplasia -- r_associated #0: 30 / 1 -> en:congenital adrenal hyperplasia
    n1=en:c-cell hyperplasia | n2=en:congenital adrenal hyperplasia | rel=r_associated | relid=0 | w=30
  2. en:c-cell hyperplasia -- r_associated #0: 30 / 1 -> en:congenital anomaly of the thyroid gland
    n1=en:c-cell hyperplasia | n2=en:congenital anomaly of the thyroid gland | rel=r_associated | relid=0 | w=30
  3. en:c-cell hyperplasia -- r_associated #0: 30 / 1 -> en:infarction of thyroid
    n1=en:c-cell hyperplasia | n2=en:infarction of thyroid | rel=r_associated | relid=0 | w=30
  4. en:c-cell hyperplasia -- r_associated #0: 30 / 1 -> en:multiple endocrine neoplasia type 2a
    n1=en:c-cell hyperplasia | n2=en:multiple endocrine neoplasia type 2a | rel=r_associated | relid=0 | w=30
  5. en:c-cell hyperplasia -- r_associated #0: 30 / 1 -> en:panhypopituitarism
    n1=en:c-cell hyperplasia | n2=en:panhypopituitarism | rel=r_associated | relid=0 | w=30
  6. en:c-cell hyperplasia -- r_associated #0: 30 / 1 -> en:pituitary dwarfism
    n1=en:c-cell hyperplasia | n2=en:pituitary dwarfism | rel=r_associated | relid=0 | w=30
  7. en:c-cell hyperplasia -- r_associated #0: 30 / 1 -> en:thyroid gland abscess
    n1=en:c-cell hyperplasia | n2=en:thyroid gland abscess | rel=r_associated | relid=0 | w=30
  8. en:c-cell hyperplasia -- r_associated #0: 29 / 0.967 -> en:adrenal hyperplasia, bilateral
    n1=en:c-cell hyperplasia | n2=en:adrenal hyperplasia, bilateral | rel=r_associated | relid=0 | w=29
  9. en:c-cell hyperplasia -- r_associated #0: 29 / 0.967 -> en:female infertility
    n1=en:c-cell hyperplasia | n2=en:female infertility | rel=r_associated | relid=0 | w=29
  10. en:c-cell hyperplasia -- r_associated #0: 29 / 0.967 -> en:normal pituitary function
    n1=en:c-cell hyperplasia | n2=en:normal pituitary function | rel=r_associated | relid=0 | w=29
  11. en:c-cell hyperplasia -- r_associated #0: 29 / 0.967 -> en:stein-leventhal syndrome
    n1=en:c-cell hyperplasia | n2=en:stein-leventhal syndrome | rel=r_associated | relid=0 | w=29
  12. en:c-cell hyperplasia -- r_associated #0: 29 / 0.967 -> en:thyroid disorders nec
    n1=en:c-cell hyperplasia | n2=en:thyroid disorders nec | rel=r_associated | relid=0 | w=29
  13. en:c-cell hyperplasia -- r_associated #0: 28 / 0.933 -> en:congenital absence of thymus
    n1=en:c-cell hyperplasia | n2=en:congenital absence of thymus | rel=r_associated | relid=0 | w=28
  14. en:c-cell hyperplasia -- r_associated #0: 28 / 0.933 -> en:diffuse c-cell hyperplasia
    n1=en:c-cell hyperplasia | n2=en:diffuse c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  15. en:c-cell hyperplasia -- r_associated #0: 28 / 0.933 -> en:maturity-onset diabetes of the young
    n1=en:c-cell hyperplasia | n2=en:maturity-onset diabetes of the young | rel=r_associated | relid=0 | w=28
  16. en:c-cell hyperplasia -- r_associated #0: 28 / 0.933 -> infertilité féminine
    n1=en:c-cell hyperplasia | n2=infertilité féminine | rel=r_associated | relid=0 | w=28
  17. en:c-cell hyperplasia -- r_associated #0: 27 / 0.9 -> en:congenital goiter
    n1=en:c-cell hyperplasia | n2=en:congenital goiter | rel=r_associated | relid=0 | w=27
  18. en:c-cell hyperplasia -- r_associated #0: 27 / 0.9 -> en:cushing disease
    n1=en:c-cell hyperplasia | n2=en:cushing disease | rel=r_associated | relid=0 | w=27
  19. en:c-cell hyperplasia -- r_associated #0: 27 / 0.9 -> en:growth hormone deficiency
    n1=en:c-cell hyperplasia | n2=en:growth hormone deficiency | rel=r_associated | relid=0 | w=27
  20. en:c-cell hyperplasia -- r_associated #0: 27 / 0.9 -> en:hypernatremia
    n1=en:c-cell hyperplasia | n2=en:hypernatremia | rel=r_associated | relid=0 | w=27
  21. en:c-cell hyperplasia -- r_associated #0: 27 / 0.9 -> en:hypoaldosteronemia
    n1=en:c-cell hyperplasia | n2=en:hypoaldosteronemia | rel=r_associated | relid=0 | w=27
  22. en:c-cell hyperplasia -- r_associated #0: 27 / 0.9 -> en:perinatal thyroid disorder
    n1=en:c-cell hyperplasia | n2=en:perinatal thyroid disorder | rel=r_associated | relid=0 | w=27
  23. en:c-cell hyperplasia -- r_associated #0: 27 / 0.9 -> en:persistent thyroglossal duct
    n1=en:c-cell hyperplasia | n2=en:persistent thyroglossal duct | rel=r_associated | relid=0 | w=27
  24. en:c-cell hyperplasia -- r_associated #0: 27 / 0.9 -> en:thyroid hyperplasia
    n1=en:c-cell hyperplasia | n2=en:thyroid hyperplasia | rel=r_associated | relid=0 | w=27
  25. en:c-cell hyperplasia -- r_associated #0: 27 / 0.9 -> en:thyroiditis
    n1=en:c-cell hyperplasia | n2=en:thyroiditis | rel=r_associated | relid=0 | w=27
  26. en:c-cell hyperplasia -- r_associated #0: 26 / 0.867 -> en:adrenal gland hyperplasia
    n1=en:c-cell hyperplasia | n2=en:adrenal gland hyperplasia | rel=r_associated | relid=0 | w=26
  27. en:c-cell hyperplasia -- r_associated #0: 26 / 0.867 -> en:congenital absence of adrenal gland
    n1=en:c-cell hyperplasia | n2=en:congenital absence of adrenal gland | rel=r_associated | relid=0 | w=26
  28. en:c-cell hyperplasia -- r_associated #0: 26 / 0.867 -> en:congenital absence of parathyroid gland
    n1=en:c-cell hyperplasia | n2=en:congenital absence of parathyroid gland | rel=r_associated | relid=0 | w=26
  29. en:c-cell hyperplasia -- r_associated #0: 26 / 0.867 -> en:hyperaldosteronism
    n1=en:c-cell hyperplasia | n2=en:hyperaldosteronism | rel=r_associated | relid=0 | w=26
  30. en:c-cell hyperplasia -- r_associated #0: 26 / 0.867 -> en:hypopituitarism
    n1=en:c-cell hyperplasia | n2=en:hypopituitarism | rel=r_associated | relid=0 | w=26
  31. en:c-cell hyperplasia -- r_associated #0: 26 / 0.867 -> en:injury of thyroid gland
    n1=en:c-cell hyperplasia | n2=en:injury of thyroid gland | rel=r_associated | relid=0 | w=26
  32. en:c-cell hyperplasia -- r_associated #0: 26 / 0.867 -> en:islets of langerhans hyperplasia
    n1=en:c-cell hyperplasia | n2=en:islets of langerhans hyperplasia | rel=r_associated | relid=0 | w=26
  33. en:c-cell hyperplasia -- r_associated #0: 26 / 0.867 -> en:thyroid calcification
    n1=en:c-cell hyperplasia | n2=en:thyroid calcification | rel=r_associated | relid=0 | w=26
  34. en:c-cell hyperplasia -- r_associated #0: 26 / 0.867 -> en:thyroid hormone binding abnormality
    n1=en:c-cell hyperplasia | n2=en:thyroid hormone binding abnormality | rel=r_associated | relid=0 | w=26
  35. en:c-cell hyperplasia -- r_associated #0: 26 / 0.867 -> stérilité féminine
    n1=en:c-cell hyperplasia | n2=stérilité féminine | rel=r_associated | relid=0 | w=26
  36. en:c-cell hyperplasia -- r_associated #0: 25 / 0.833 -> en:congenital adrenal gland hypoplasia
    n1=en:c-cell hyperplasia | n2=en:congenital adrenal gland hypoplasia | rel=r_associated | relid=0 | w=25
  37. en:c-cell hyperplasia -- r_associated #0: 25 / 0.833 -> en:euthyroid (finding)
    n1=en:c-cell hyperplasia | n2=en:euthyroid (finding) | rel=r_associated | relid=0 | w=25
  38. en:c-cell hyperplasia -- r_associated #0: 25 / 0.833 -> en:focal epithelial hyperplasia
    n1=en:c-cell hyperplasia | n2=en:focal epithelial hyperplasia | rel=r_associated | relid=0 | w=25
  39. en:c-cell hyperplasia -- r_associated #0: 25 / 0.833 -> en:multinodular goiter
    n1=en:c-cell hyperplasia | n2=en:multinodular goiter | rel=r_associated | relid=0 | w=25
  40. en:c-cell hyperplasia -- r_associated #0: 25 / 0.833 -> infertilité de la femme
    n1=en:c-cell hyperplasia | n2=infertilité de la femme | rel=r_associated | relid=0 | w=25
  41. en:c-cell hyperplasia -- r_associated #0: 24 / 0.8 -> en:cervical neuroendocrine carcinoma
    n1=en:c-cell hyperplasia | n2=en:cervical neuroendocrine carcinoma | rel=r_associated | relid=0 | w=24
  42. en:c-cell hyperplasia -- r_associated #0: 24 / 0.8 -> en:hashimoto thyroiditis
    n1=en:c-cell hyperplasia | n2=en:hashimoto thyroiditis | rel=r_associated | relid=0 | w=24
  43. en:c-cell hyperplasia -- r_associated #0: 24 / 0.8 -> en:hypoinsulinaemia (disorder)
    n1=en:c-cell hyperplasia | n2=en:hypoinsulinaemia (disorder) | rel=r_associated | relid=0 | w=24
  44. en:c-cell hyperplasia -- r_associated #0: 24 / 0.8 -> en:klinefelter syndrome
    n1=en:c-cell hyperplasia | n2=en:klinefelter syndrome | rel=r_associated | relid=0 | w=24
  45. en:c-cell hyperplasia -- r_associated #0: 24 / 0.8 -> en:neonatal diabetes mellitus
    n1=en:c-cell hyperplasia | n2=en:neonatal diabetes mellitus | rel=r_associated | relid=0 | w=24
  46. en:c-cell hyperplasia -- r_associated #0: 24 / 0.8 -> en:precocious puberty
    n1=en:c-cell hyperplasia | n2=en:precocious puberty | rel=r_associated | relid=0 | w=24
  47. en:c-cell hyperplasia -- r_associated #0: 24 / 0.8 -> hyperandrogénie
    n1=en:c-cell hyperplasia | n2=hyperandrogénie | rel=r_associated | relid=0 | w=24
  48. en:c-cell hyperplasia -- r_associated #0: 24 / 0.8 -> hyperandrogénisme
    n1=en:c-cell hyperplasia | n2=hyperandrogénisme | rel=r_associated | relid=0 | w=24
  49. en:c-cell hyperplasia -- r_associated #0: 23 / 0.767 -> en:adrenal hypoplasia
    n1=en:c-cell hyperplasia | n2=en:adrenal hypoplasia | rel=r_associated | relid=0 | w=23
  50. en:c-cell hyperplasia -- r_associated #0: 23 / 0.767 -> en:epidermal hyperplasia
    n1=en:c-cell hyperplasia | n2=en:epidermal hyperplasia | rel=r_associated | relid=0 | w=23
  51. en:c-cell hyperplasia -- r_associated #0: 23 / 0.767 -> en:hypogonadotropic hypogonadism
    n1=en:c-cell hyperplasia | n2=en:hypogonadotropic hypogonadism | rel=r_associated | relid=0 | w=23
  52. en:c-cell hyperplasia -- r_associated #0: 23 / 0.767 -> en:inherited disorder of thyroid metabolism
    n1=en:c-cell hyperplasia | n2=en:inherited disorder of thyroid metabolism | rel=r_associated | relid=0 | w=23
  53. en:c-cell hyperplasia -- r_associated #0: 23 / 0.767 -> en:multiple endocrine neoplasia type 2b
    n1=en:c-cell hyperplasia | n2=en:multiple endocrine neoplasia type 2b | rel=r_associated | relid=0 | w=23
  54. en:c-cell hyperplasia -- r_associated #0: 23 / 0.767 -> en:secondary hyperparathyroidism
    n1=en:c-cell hyperplasia | n2=en:secondary hyperparathyroidism | rel=r_associated | relid=0 | w=23
  55. en:c-cell hyperplasia -- r_associated #0: 23 / 0.767 -> hypogonadisme hypogonadotrophique
    n1=en:c-cell hyperplasia | n2=hypogonadisme hypogonadotrophique | rel=r_associated | relid=0 | w=23
  56. en:c-cell hyperplasia -- r_associated #0: 22 / 0.733 -> en:diabetes mellitus
    n1=en:c-cell hyperplasia | n2=en:diabetes mellitus | rel=r_associated | relid=0 | w=22
  57. en:c-cell hyperplasia -- r_associated #0: 22 / 0.733 -> en:pituitary hormone deficiency
    n1=en:c-cell hyperplasia | n2=en:pituitary hormone deficiency | rel=r_associated | relid=0 | w=22
  58. en:c-cell hyperplasia -- r_associated #0: 22 / 0.733 -> en:thyroglossal duct cyst
    n1=en:c-cell hyperplasia | n2=en:thyroglossal duct cyst | rel=r_associated | relid=0 | w=22
  59. en:c-cell hyperplasia -- r_associated #0: 22 / 0.733 -> en:thyroid cyst
    n1=en:c-cell hyperplasia | n2=en:thyroid cyst | rel=r_associated | relid=0 | w=22
  60. en:c-cell hyperplasia -- r_associated #0: 21 / 0.7 -> en:adrenal hyperplasia
    n1=en:c-cell hyperplasia | n2=en:adrenal hyperplasia | rel=r_associated | relid=0 | w=21
  61. en:c-cell hyperplasia -- r_associated #0: 21 / 0.7 -> en:androgen excess
    n1=en:c-cell hyperplasia | n2=en:androgen excess | rel=r_associated | relid=0 | w=21
  62. en:c-cell hyperplasia -- r_associated #0: 21 / 0.7 -> en:denture-induced fibrous hyperplasia
    n1=en:c-cell hyperplasia | n2=en:denture-induced fibrous hyperplasia | rel=r_associated | relid=0 | w=21
  63. en:c-cell hyperplasia -- r_associated #0: 21 / 0.7 -> en:enlarged adrenal gland
    n1=en:c-cell hyperplasia | n2=en:enlarged adrenal gland | rel=r_associated | relid=0 | w=21
  64. en:c-cell hyperplasia -- r_associated #0: 21 / 0.7 -> en:hypercortisolemia
    n1=en:c-cell hyperplasia | n2=en:hypercortisolemia | rel=r_associated | relid=0 | w=21
  65. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> acanthosis
    n1=en:c-cell hyperplasia | n2=acanthosis | rel=r_associated | relid=0 | w=20
  66. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> acromégalie
    n1=en:c-cell hyperplasia | n2=acromégalie | rel=r_associated | relid=0 | w=20
  67. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> acromegaly
    n1=en:c-cell hyperplasia | n2=acromegaly | rel=r_associated | relid=0 | w=20
  68. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> adénome de la prostate
    n1=en:c-cell hyperplasia | n2=adénome de la prostate | rel=r_associated | relid=0 | w=20
  69. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> adénome prostatique
    n1=en:c-cell hyperplasia | n2=adénome prostatique | rel=r_associated | relid=0 | w=20
  70. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> asynergie oculo-palpébrale
    n1=en:c-cell hyperplasia | n2=asynergie oculo-palpébrale | rel=r_associated | relid=0 | w=20
  71. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> atrophie congénitale de la thyroïde
    n1=en:c-cell hyperplasia | n2=atrophie congénitale de la thyroïde | rel=r_associated | relid=0 | w=20
  72. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> corps thyroïde
    n1=en:c-cell hyperplasia | n2=corps thyroïde | rel=r_associated | relid=0 | w=20
  73. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> crétinismes
    n1=en:c-cell hyperplasia | n2=crétinismes | rel=r_associated | relid=0 | w=20
  74. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> déficit en hormone de croissance
    n1=en:c-cell hyperplasia | n2=déficit en hormone de croissance | rel=r_associated | relid=0 | w=20
  75. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> diabète (accidents vasculaires cérébraux du)
    n1=en:c-cell hyperplasia | n2=diabète (accidents vasculaires cérébraux du) | rel=r_associated | relid=0 | w=20
  76. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> diabète sucré
    n1=en:c-cell hyperplasia | n2=diabète sucré | rel=r_associated | relid=0 | w=20
  77. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> diabète sucré de type 2 avec surdité
    n1=en:c-cell hyperplasia | n2=diabète sucré de type 2 avec surdité | rel=r_associated | relid=0 | w=20
  78. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale
    n1=en:c-cell hyperplasia | n2=diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale | rel=r_associated | relid=0 | w=20
  79. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:abnormal glucose tolerance test
    n1=en:c-cell hyperplasia | n2=en:abnormal glucose tolerance test | rel=r_associated | relid=0 | w=20
  80. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:absent anti-mullerian hormone
    n1=en:c-cell hyperplasia | n2=en:absent anti-mullerian hormone | rel=r_associated | relid=0 | w=20
  81. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:acanthosis
    n1=en:c-cell hyperplasia | n2=en:acanthosis | rel=r_associated | relid=0 | w=20
  82. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:acromegaly
    n1=en:c-cell hyperplasia | n2=en:acromegaly | rel=r_associated | relid=0 | w=20
  83. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:addison disease
    n1=en:c-cell hyperplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  84. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:Addison disease
    n1=en:c-cell hyperplasia | n2=en:Addison disease | rel=r_associated | relid=0 | w=20
  85. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:Addison's disease
    n1=en:c-cell hyperplasia | n2=en:Addison's disease | rel=r_associated | relid=0 | w=20
  86. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:addison's disease
    n1=en:c-cell hyperplasia | n2=en:addison's disease | rel=r_associated | relid=0 | w=20
  87. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:adenomyomatosis
    n1=en:c-cell hyperplasia | n2=en:adenomyomatosis | rel=r_associated | relid=0 | w=20
  88. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:adrenal agenesis/dysgenesis
    n1=en:c-cell hyperplasia | n2=en:adrenal agenesis/dysgenesis | rel=r_associated | relid=0 | w=20
  89. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:adrenal cortex adenoma
    n1=en:c-cell hyperplasia | n2=en:adrenal cortex adenoma | rel=r_associated | relid=0 | w=20
  90. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:aldosterone level increased above normal
    n1=en:c-cell hyperplasia | n2=en:aldosterone level increased above normal | rel=r_associated | relid=0 | w=20
  91. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:and cerebellar ataxia due to duplication of mitochondrial DNA
    n1=en:c-cell hyperplasia | n2=en:and cerebellar ataxia due to duplication of mitochondrial DNA | rel=r_associated | relid=0 | w=20
  92. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:atypical hyperplasia
    n1=en:c-cell hyperplasia | n2=en:atypical hyperplasia | rel=r_associated | relid=0 | w=20
  93. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:autoimmune thyroiditis
    n1=en:c-cell hyperplasia | n2=en:autoimmune thyroiditis | rel=r_associated | relid=0 | w=20
  94. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:basosquamous acanthoma
    n1=en:c-cell hyperplasia | n2=en:basosquamous acanthoma | rel=r_associated | relid=0 | w=20
  95. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:benign neoplasm of prostate
    n1=en:c-cell hyperplasia | n2=en:benign neoplasm of prostate | rel=r_associated | relid=0 | w=20
  96. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:benign overgrowth of the prostate
    n1=en:c-cell hyperplasia | n2=en:benign overgrowth of the prostate | rel=r_associated | relid=0 | w=20
  97. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:benign prostate hypertrophy
    n1=en:c-cell hyperplasia | n2=en:benign prostate hypertrophy | rel=r_associated | relid=0 | w=20
  98. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:benign prostate neoplasm
    n1=en:c-cell hyperplasia | n2=en:benign prostate neoplasm | rel=r_associated | relid=0 | w=20
  99. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:benign prostatic hyperplasia
    n1=en:c-cell hyperplasia | n2=en:benign prostatic hyperplasia | rel=r_associated | relid=0 | w=20
  100. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:benign prostatic hypertrophy
    n1=en:c-cell hyperplasia | n2=en:benign prostatic hypertrophy | rel=r_associated | relid=0 | w=20
  101. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:bone marrow hyperplasia
    n1=en:c-cell hyperplasia | n2=en:bone marrow hyperplasia | rel=r_associated | relid=0 | w=20
  102. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:c-cell
    n1=en:c-cell hyperplasia | n2=en:c-cell | rel=r_associated | relid=0 | w=20
  103. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:c-cell hyperplasia multifocal
    n1=en:c-cell hyperplasia | n2=en:c-cell hyperplasia multifocal | rel=r_associated | relid=0 | w=20
  104. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:congenital atrophy of thyroid
    n1=en:c-cell hyperplasia | n2=en:congenital atrophy of thyroid | rel=r_associated | relid=0 | w=20
  105. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:congenital hypoplasia of thymus
    n1=en:c-cell hyperplasia | n2=en:congenital hypoplasia of thymus | rel=r_associated | relid=0 | w=20
  106. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:congenital hypothyroidism
    n1=en:c-cell hyperplasia | n2=en:congenital hypothyroidism | rel=r_associated | relid=0 | w=20
  107. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:congenital iodine deficiency hypothyroidism
    n1=en:c-cell hyperplasia | n2=en:congenital iodine deficiency hypothyroidism | rel=r_associated | relid=0 | w=20
  108. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:connective tissue hyperplasia
    n1=en:c-cell hyperplasia | n2=en:connective tissue hyperplasia | rel=r_associated | relid=0 | w=20
  109. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:cushing syndrome
    n1=en:c-cell hyperplasia | n2=en:cushing syndrome | rel=r_associated | relid=0 | w=20
  110. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:decreased circulating renin level
    n1=en:c-cell hyperplasia | n2=en:decreased circulating renin level | rel=r_associated | relid=0 | w=20
  111. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:decreased testosterone level
    n1=en:c-cell hyperplasia | n2=en:decreased testosterone level | rel=r_associated | relid=0 | w=20
  112. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:delayed puberty
    n1=en:c-cell hyperplasia | n2=en:delayed puberty | rel=r_associated | relid=0 | w=20
  113. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:delayed puberty (in most patients)
    n1=en:c-cell hyperplasia | n2=en:delayed puberty (in most patients) | rel=r_associated | relid=0 | w=20
  114. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:drug induced gingival hyperplasia
    n1=en:c-cell hyperplasia | n2=en:drug induced gingival hyperplasia | rel=r_associated | relid=0 | w=20
  115. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:ectopic thyroid gland
    n1=en:c-cell hyperplasia | n2=en:ectopic thyroid gland | rel=r_associated | relid=0 | w=20
  116. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:elevated baseline 17-hydroxypregnenolone levels
    n1=en:c-cell hyperplasia | n2=en:elevated baseline 17-hydroxypregnenolone levels | rel=r_associated | relid=0 | w=20
  117. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:elevated fasting glucose
    n1=en:c-cell hyperplasia | n2=en:elevated fasting glucose | rel=r_associated | relid=0 | w=20
  118. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:elevated fasting plasma glucose
    n1=en:c-cell hyperplasia | n2=en:elevated fasting plasma glucose | rel=r_associated | relid=0 | w=20
  119. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:elevated gonadotropin levels
    n1=en:c-cell hyperplasia | n2=en:elevated gonadotropin levels | rel=r_associated | relid=0 | w=20
  120. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:encephalopathy with intracranial calcification
    n1=en:c-cell hyperplasia | n2=en:encephalopathy with intracranial calcification | rel=r_associated | relid=0 | w=20
  121. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:focal hyperplasia
    n1=en:c-cell hyperplasia | n2=en:focal hyperplasia | rel=r_associated | relid=0 | w=20
  122. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:focal nodular hyperplasia
    n1=en:c-cell hyperplasia | n2=en:focal nodular hyperplasia | rel=r_associated | relid=0 | w=20
  123. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:glandula thyroidea
    n1=en:c-cell hyperplasia | n2=en:glandula thyroidea | rel=r_associated | relid=0 | w=20
  124. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:glandular and stromal hyperplasia
    n1=en:c-cell hyperplasia | n2=en:glandular and stromal hyperplasia | rel=r_associated | relid=0 | w=20
  125. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:glucagonoma syndrome
    n1=en:c-cell hyperplasia | n2=en:glucagonoma syndrome | rel=r_associated | relid=0 | w=20
  126. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:gonadotrophin increased
    n1=en:c-cell hyperplasia | n2=en:gonadotrophin increased | rel=r_associated | relid=0 | w=20
  127. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:haemorrhagic thyroid cyst
    n1=en:c-cell hyperplasia | n2=en:haemorrhagic thyroid cyst | rel=r_associated | relid=0 | w=20
  128. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:head and neck
    n1=en:c-cell hyperplasia | n2=en:head and neck | rel=r_associated | relid=0 | w=20
  129. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:Heck's disease
    n1=en:c-cell hyperplasia | n2=en:Heck's disease | rel=r_associated | relid=0 | w=20
  130. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hyperandrogenism
    n1=en:c-cell hyperplasia | n2=en:hyperandrogenism | rel=r_associated | relid=0 | w=20
  131. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hyperandrogeny
    n1=en:c-cell hyperplasia | n2=en:hyperandrogeny | rel=r_associated | relid=0 | w=20
  132. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hypercalcemia
    n1=en:c-cell hyperplasia | n2=en:hypercalcemia | rel=r_associated | relid=0 | w=20
  133. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hyperinsulinemic hypoglycemia
    n1=en:c-cell hyperplasia | n2=en:hyperinsulinemic hypoglycemia | rel=r_associated | relid=0 | w=20
  134. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis
    n1=en:c-cell hyperplasia | n2=en:hyperkeratosis | rel=r_associated | relid=0 | w=20
  135. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hypernatraemia
    n1=en:c-cell hyperplasia | n2=en:hypernatraemia | rel=r_associated | relid=0 | w=20
  136. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hyperplastic tissue present
    n1=en:c-cell hyperplasia | n2=en:hyperplastic tissue present | rel=r_associated | relid=0 | w=20
  137. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hyperprolactinemia
    n1=en:c-cell hyperplasia | n2=en:hyperprolactinemia | rel=r_associated | relid=0 | w=20
  138. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hyperthyroidism
    n1=en:c-cell hyperplasia | n2=en:hyperthyroidism | rel=r_associated | relid=0 | w=20
  139. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hypoaldosteronism
    n1=en:c-cell hyperplasia | n2=en:hypoaldosteronism | rel=r_associated | relid=0 | w=20
  140. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hypocalcemia
    n1=en:c-cell hyperplasia | n2=en:hypocalcemia | rel=r_associated | relid=0 | w=20
  141. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hypoglycemia, fasting
    n1=en:c-cell hyperplasia | n2=en:hypoglycemia, fasting | rel=r_associated | relid=0 | w=20
  142. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hypogonadotrophic hypogonadism
    n1=en:c-cell hyperplasia | n2=en:hypogonadotrophic hypogonadism | rel=r_associated | relid=0 | w=20
  143. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hypothalamic hamartoblastoma
    n1=en:c-cell hyperplasia | n2=en:hypothalamic hamartoblastoma | rel=r_associated | relid=0 | w=20
  144. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hypothyreosis
    n1=en:c-cell hyperplasia | n2=en:hypothyreosis | rel=r_associated | relid=0 | w=20
  145. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hypothyroidism
    n1=en:c-cell hyperplasia | n2=en:hypothyroidism | rel=r_associated | relid=0 | w=20
  146. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:hypothyroidy
    n1=en:c-cell hyperplasia | n2=en:hypothyroidy | rel=r_associated | relid=0 | w=20
  147. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:infertilitas feminis
    n1=en:c-cell hyperplasia | n2=en:infertilitas feminis | rel=r_associated | relid=0 | w=20
  148. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:intraductal hyperplasia
    n1=en:c-cell hyperplasia | n2=en:intraductal hyperplasia | rel=r_associated | relid=0 | w=20
  149. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:iodine-deficiency-related thyroid disorders and allied conditions
    n1=en:c-cell hyperplasia | n2=en:iodine-deficiency-related thyroid disorders and allied conditions | rel=r_associated | relid=0 | w=20
  150. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:Klinefelter syndrome
    n1=en:c-cell hyperplasia | n2=en:Klinefelter syndrome | rel=r_associated | relid=0 | w=20
  151. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:lid lag
    n1=en:c-cell hyperplasia | n2=en:lid lag | rel=r_associated | relid=0 | w=20
  152. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:low serum igf2 levels
    n1=en:c-cell hyperplasia | n2=en:low serum igf2 levels | rel=r_associated | relid=0 | w=20
  153. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:low to normal estradiol levels
    n1=en:c-cell hyperplasia | n2=en:low to normal estradiol levels | rel=r_associated | relid=0 | w=20
  154. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:lymphoid hyperplasia
    n1=en:c-cell hyperplasia | n2=en:lymphoid hyperplasia | rel=r_associated | relid=0 | w=20
  155. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:mass of thyroid gland
    n1=en:c-cell hyperplasia | n2=en:mass of thyroid gland | rel=r_associated | relid=0 | w=20
  156. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:nasal alar hypoplasia
    n1=en:c-cell hyperplasia | n2=en:nasal alar hypoplasia | rel=r_associated | relid=0 | w=20
  157. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:neonatal hypoglycemia
    n1=en:c-cell hyperplasia | n2=en:neonatal hypoglycemia | rel=r_associated | relid=0 | w=20
  158. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:neonatal hypothyroidism
    n1=en:c-cell hyperplasia | n2=en:neonatal hypothyroidism | rel=r_associated | relid=0 | w=20
  159. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:neuroendocrine cell hyperplasia of infancy
    n1=en:c-cell hyperplasia | n2=en:neuroendocrine cell hyperplasia of infancy | rel=r_associated | relid=0 | w=20
  160. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:nodular hyperplasia
    n1=en:c-cell hyperplasia | n2=en:nodular hyperplasia | rel=r_associated | relid=0 | w=20
  161. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:normal basal plasma cortisol
    n1=en:c-cell hyperplasia | n2=en:normal basal plasma cortisol | rel=r_associated | relid=0 | w=20
  162. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:normal serum igfbp3 levels
    n1=en:c-cell hyperplasia | n2=en:normal serum igfbp3 levels | rel=r_associated | relid=0 | w=20
  163. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:other nontoxic goitre
    n1=en:c-cell hyperplasia | n2=en:other nontoxic goitre | rel=r_associated | relid=0 | w=20
  164. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:overactive thyroid
    n1=en:c-cell hyperplasia | n2=en:overactive thyroid | rel=r_associated | relid=0 | w=20
  165. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:pachyderma
    n1=en:c-cell hyperplasia | n2=en:pachyderma | rel=r_associated | relid=0 | w=20
  166. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:pain in thyroid
    n1=en:c-cell hyperplasia | n2=en:pain in thyroid | rel=r_associated | relid=0 | w=20
  167. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:parathyroid gland adenoma
    n1=en:c-cell hyperplasia | n2=en:parathyroid gland adenoma | rel=r_associated | relid=0 | w=20
  168. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:premature thelarche
    n1=en:c-cell hyperplasia | n2=en:premature thelarche | rel=r_associated | relid=0 | w=20
  169. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:primary hypothyroidism
    n1=en:c-cell hyperplasia | n2=en:primary hypothyroidism | rel=r_associated | relid=0 | w=20
  170. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:prostate adenoma
    n1=en:c-cell hyperplasia | n2=en:prostate adenoma | rel=r_associated | relid=0 | w=20
  171. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:prostatic adenoma
    n1=en:c-cell hyperplasia | n2=en:prostatic adenoma | rel=r_associated | relid=0 | w=20
  172. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:pseudohypoparathyroidism
    n1=en:c-cell hyperplasia | n2=en:pseudohypoparathyroidism | rel=r_associated | relid=0 | w=20
  173. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:reactive hypoglycemia
    n1=en:c-cell hyperplasia | n2=en:reactive hypoglycemia | rel=r_associated | relid=0 | w=20
  174. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:renal tubulopathy
    n1=en:c-cell hyperplasia | n2=en:renal tubulopathy | rel=r_associated | relid=0 | w=20
  175. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:reticuloendothelial hyperplasia
    n1=en:c-cell hyperplasia | n2=en:reticuloendothelial hyperplasia | rel=r_associated | relid=0 | w=20
  176. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:sebaceous hyperplasia
    n1=en:c-cell hyperplasia | n2=en:sebaceous hyperplasia | rel=r_associated | relid=0 | w=20
  177. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:secondary adrenal insufficiency
    n1=en:c-cell hyperplasia | n2=en:secondary adrenal insufficiency | rel=r_associated | relid=0 | w=20
  178. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:sick euthyroid syndrome
    n1=en:c-cell hyperplasia | n2=en:sick euthyroid syndrome | rel=r_associated | relid=0 | w=20
  179. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:skin hyperplasia
    n1=en:c-cell hyperplasia | n2=en:skin hyperplasia | rel=r_associated | relid=0 | w=20
  180. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:sugar diabetes
    n1=en:c-cell hyperplasia | n2=en:sugar diabetes | rel=r_associated | relid=0 | w=20
  181. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:syndrome of inappropriate antidiuretic hormone secretion
    n1=en:c-cell hyperplasia | n2=en:syndrome of inappropriate antidiuretic hormone secretion | rel=r_associated | relid=0 | w=20
  182. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:thyroglossal cyst
    n1=en:c-cell hyperplasia | n2=en:thyroglossal cyst | rel=r_associated | relid=0 | w=20
  183. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:thyroid body
    n1=en:c-cell hyperplasia | n2=en:thyroid body | rel=r_associated | relid=0 | w=20
  184. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:thyroid dysfunction
    n1=en:c-cell hyperplasia | n2=en:thyroid dysfunction | rel=r_associated | relid=0 | w=20
  185. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:thyroid dysfunction of mother, antepartum condition or complication
    n1=en:c-cell hyperplasia | n2=en:thyroid dysfunction of mother, antepartum condition or complication | rel=r_associated | relid=0 | w=20
  186. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:thyroid dysgenesis
    n1=en:c-cell hyperplasia | n2=en:thyroid dysgenesis | rel=r_associated | relid=0 | w=20
  187. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:thyroid function normal
    n1=en:c-cell hyperplasia | n2=en:thyroid function normal | rel=r_associated | relid=0 | w=20
  188. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:thyroid gland
    n1=en:c-cell hyperplasia | n2=en:thyroid gland | rel=r_associated | relid=0 | w=20
  189. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:thyroid gland follicle
    n1=en:c-cell hyperplasia | n2=en:thyroid gland follicle | rel=r_associated | relid=0 | w=20
  190. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:thyroid gland follicular adenoma
    n1=en:c-cell hyperplasia | n2=en:thyroid gland follicular adenoma | rel=r_associated | relid=0 | w=20
  191. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:thyroid gland papillary carcinoma
    n1=en:c-cell hyperplasia | n2=en:thyroid gland papillary carcinoma | rel=r_associated | relid=0 | w=20
  192. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:thyroid oncocytic metaplasia
    n1=en:c-cell hyperplasia | n2=en:thyroid oncocytic metaplasia | rel=r_associated | relid=0 | w=20
  193. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:thyrotoxicosis [hyperthyroidism]
    n1=en:c-cell hyperplasia | n2=en:thyrotoxicosis [hyperthyroidism] | rel=r_associated | relid=0 | w=20
  194. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> en:uroglycosis
    n1=en:c-cell hyperplasia | n2=en:uroglycosis | rel=r_associated | relid=0 | w=20
  195. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> encéphalopathie avec calcification intracrânienne, déficience en hormone de croissance, microcéphalie et dégénérescence rétinienne
    n1=en:c-cell hyperplasia | n2=encéphalopathie avec calcification intracrânienne, déficience en hormone de croissance, microcéphalie et dégénérescence rétinienne | rel=r_associated | relid=0 | w=20
  196. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> glande thyroïde
    n1=en:c-cell hyperplasia | n2=glande thyroïde | rel=r_associated | relid=0 | w=20
  197. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> Glande thyroïde
    n1=en:c-cell hyperplasia | n2=Glande thyroïde | rel=r_associated | relid=0 | w=20
  198. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> glucagonome (syndrome du)
    n1=en:c-cell hyperplasia | n2=glucagonome (syndrome du) | rel=r_associated | relid=0 | w=20
  199. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> goitre congénital
    n1=en:c-cell hyperplasia | n2=goitre congénital | rel=r_associated | relid=0 | w=20
  200. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> goitre multinodulaire
    n1=en:c-cell hyperplasia | n2=goitre multinodulaire | rel=r_associated | relid=0 | w=20
  201. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hamartoblastome hypothalamique, hypopituitarisme, imperforation anale et polydactylie post-axiale
    n1=en:c-cell hyperplasia | n2=hamartoblastome hypothalamique, hypopituitarisme, imperforation anale et polydactylie post-axiale | rel=r_associated | relid=0 | w=20
  202. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hyperacanthose
    n1=en:c-cell hyperplasia | n2=hyperacanthose | rel=r_associated | relid=0 | w=20
  203. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hyperaldostéronisme
    n1=en:c-cell hyperplasia | n2=hyperaldostéronisme | rel=r_associated | relid=0 | w=20
  204. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hypercalcémie
    n1=en:c-cell hyperplasia | n2=hypercalcémie | rel=r_associated | relid=0 | w=20
  205. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hyperkératose
    n1=en:c-cell hyperplasia | n2=hyperkératose | rel=r_associated | relid=0 | w=20
  206. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hyperkeratosis
    n1=en:c-cell hyperplasia | n2=hyperkeratosis | rel=r_associated | relid=0 | w=20
  207. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hyperplasie atypique
    n1=en:c-cell hyperplasia | n2=hyperplasie atypique | rel=r_associated | relid=0 | w=20
  208. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hyperplasie bénigne de la prostate
    n1=en:c-cell hyperplasia | n2=hyperplasie bénigne de la prostate | rel=r_associated | relid=0 | w=20
  209. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hyperplasie congénitale des surrénales
    n1=en:c-cell hyperplasia | n2=hyperplasie congénitale des surrénales | rel=r_associated | relid=0 | w=20
  210. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hyperplasie épithéliale focale de Heck
    n1=en:c-cell hyperplasia | n2=hyperplasie épithéliale focale de Heck | rel=r_associated | relid=0 | w=20
  211. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hyperplasie prostatique bénigne
    n1=en:c-cell hyperplasia | n2=hyperplasie prostatique bénigne | rel=r_associated | relid=0 | w=20
  212. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hyperplasie sébacée
    n1=en:c-cell hyperplasia | n2=hyperplasie sébacée | rel=r_associated | relid=0 | w=20
  213. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hyperthyroïdie
    n1=en:c-cell hyperplasia | n2=hyperthyroïdie | rel=r_associated | relid=0 | w=20
  214. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hyperthyroïdisme
    n1=en:c-cell hyperplasia | n2=hyperthyroïdisme | rel=r_associated | relid=0 | w=20
  215. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hypertrophie bénigne de la prostate
    n1=en:c-cell hyperplasia | n2=hypertrophie bénigne de la prostate | rel=r_associated | relid=0 | w=20
  216. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hypo-aldostéronisme
    n1=en:c-cell hyperplasia | n2=hypo-aldostéronisme | rel=r_associated | relid=0 | w=20
  217. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hypoaldostéronisme
    n1=en:c-cell hyperplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20
  218. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hypocalcémie
    n1=en:c-cell hyperplasia | n2=hypocalcémie | rel=r_associated | relid=0 | w=20
  219. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hypoglycémie du nouveau-né
    n1=en:c-cell hyperplasia | n2=hypoglycémie du nouveau-né | rel=r_associated | relid=0 | w=20
  220. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hypohypophysie
    n1=en:c-cell hyperplasia | n2=hypohypophysie | rel=r_associated | relid=0 | w=20
  221. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hypopituitarisme
    n1=en:c-cell hyperplasia | n2=hypopituitarisme | rel=r_associated | relid=0 | w=20
  222. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hypoplasie des ailes du nez-hypothyroïdisme-absence de sécrétion pancréatique-surdité congénitale
    n1=en:c-cell hyperplasia | n2=hypoplasie des ailes du nez-hypothyroïdisme-absence de sécrétion pancréatique-surdité congénitale | rel=r_associated | relid=0 | w=20
  223. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hypostimulinie
    n1=en:c-cell hyperplasia | n2=hypostimulinie | rel=r_associated | relid=0 | w=20
  224. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hypothyroïdie
    n1=en:c-cell hyperplasia | n2=hypothyroïdie | rel=r_associated | relid=0 | w=20
  225. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hypothyroïdie congénitale
    n1=en:c-cell hyperplasia | n2=hypothyroïdie congénitale | rel=r_associated | relid=0 | w=20
  226. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hypothyroïdisme
    n1=en:c-cell hyperplasia | n2=hypothyroïdisme | rel=r_associated | relid=0 | w=20
  227. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> hypothyroïdisme congénital
    n1=en:c-cell hyperplasia | n2=hypothyroïdisme congénital | rel=r_associated | relid=0 | w=20
  228. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> infantilisme type brissaud
    n1=en:c-cell hyperplasia | n2=infantilisme type brissaud | rel=r_associated | relid=0 | w=20
  229. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> insuffisance surrénalienne chronique primaire
    n1=en:c-cell hyperplasia | n2=insuffisance surrénalienne chronique primaire | rel=r_associated | relid=0 | w=20
  230. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> kyste du canal thyréoglosse
    n1=en:c-cell hyperplasia | n2=kyste du canal thyréoglosse | rel=r_associated | relid=0 | w=20
  231. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> kyste du canal thyroglossal
    n1=en:c-cell hyperplasia | n2=kyste du canal thyroglossal | rel=r_associated | relid=0 | w=20
  232. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> kyste du tractus thyréoglosse
    n1=en:c-cell hyperplasia | n2=kyste du tractus thyréoglosse | rel=r_associated | relid=0 | w=20
  233. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> kyste thyréoglosse
    n1=en:c-cell hyperplasia | n2=kyste thyréoglosse | rel=r_associated | relid=0 | w=20
  234. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> maladie d'Addison
    n1=en:c-cell hyperplasia | n2=maladie d'Addison | rel=r_associated | relid=0 | w=20
  235. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> maladie d'addison
    n1=en:c-cell hyperplasia | n2=maladie d'addison | rel=r_associated | relid=0 | w=20
  236. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> nanisme hypothyroïdien
    n1=en:c-cell hyperplasia | n2=nanisme hypothyroïdien | rel=r_associated | relid=0 | w=20
  237. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> pachydermie
    n1=en:c-cell hyperplasia | n2=pachydermie | rel=r_associated | relid=0 | w=20
  238. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> panhypopituitarisme
    n1=en:c-cell hyperplasia | n2=panhypopituitarisme | rel=r_associated | relid=0 | w=20
  239. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> pseudo-hypoparathyroïdie
    n1=en:c-cell hyperplasia | n2=pseudo-hypoparathyroïdie | rel=r_associated | relid=0 | w=20
  240. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> pseudo-hypoparathyroïdisme
    n1=en:c-cell hyperplasia | n2=pseudo-hypoparathyroïdisme | rel=r_associated | relid=0 | w=20
  241. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> pseudohypoparathyroïdie
    n1=en:c-cell hyperplasia | n2=pseudohypoparathyroïdie | rel=r_associated | relid=0 | w=20
  242. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> pseudohypoparathyroïdisme
    n1=en:c-cell hyperplasia | n2=pseudohypoparathyroïdisme | rel=r_associated | relid=0 | w=20
  243. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> puberté précoce
    n1=en:c-cell hyperplasia | n2=puberté précoce | rel=r_associated | relid=0 | w=20
  244. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> Puberté précoce
    n1=en:c-cell hyperplasia | n2=Puberté précoce | rel=r_associated | relid=0 | w=20
  245. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> puberté retardée
    n1=en:c-cell hyperplasia | n2=puberté retardée | rel=r_associated | relid=0 | w=20
  246. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> puberté rétardée
    n1=en:c-cell hyperplasia | n2=puberté rétardée | rel=r_associated | relid=0 | w=20
  247. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> puberté tardive
    n1=en:c-cell hyperplasia | n2=puberté tardive | rel=r_associated | relid=0 | w=20
  248. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> retard pubertaire
    n1=en:c-cell hyperplasia | n2=retard pubertaire | rel=r_associated | relid=0 | w=20
  249. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> syndrome d'insuffisance thyroïdienne congénitale
    n1=en:c-cell hyperplasia | n2=syndrome d'insuffisance thyroïdienne congénitale | rel=r_associated | relid=0 | w=20
  250. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> thyroïdite
    n1=en:c-cell hyperplasia | n2=thyroïdite | rel=r_associated | relid=0 | w=20
  251. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial
    n1=en:c-cell hyperplasia | n2=tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial | rel=r_associated | relid=0 | w=20
  252. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> tumeur bénigne de la prostate
    n1=en:c-cell hyperplasia | n2=tumeur bénigne de la prostate | rel=r_associated | relid=0 | w=20
  253. en:c-cell hyperplasia -- r_associated #0: 20 / 0.667 -> tumeur bénigne prostatique
    n1=en:c-cell hyperplasia | n2=tumeur bénigne prostatique | rel=r_associated | relid=0 | w=20
≈ 382 relations entrantes

  1. syndrome d'insuffisance thyroïdienne congénitale --- r_associated #0: 196 --> en:c-cell hyperplasia
    n1=syndrome d'insuffisance thyroïdienne congénitale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=196
  2. en:congenital goiter --- r_associated #0: 195 --> en:c-cell hyperplasia
    n1=en:congenital goiter | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=195
  3. hypothyroïdie congénitale --- r_associated #0: 195 --> en:c-cell hyperplasia
    n1=hypothyroïdie congénitale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=195
  4. infantilisme type brissaud --- r_associated #0: 195 --> en:c-cell hyperplasia
    n1=infantilisme type brissaud | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=195
  5. nanisme hypothyroïdien --- r_associated #0: 195 --> en:c-cell hyperplasia
    n1=nanisme hypothyroïdien | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=195
  6. goitre congénital --- r_associated #0: 191 --> en:c-cell hyperplasia
    n1=goitre congénital | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=191
  7. hypogonadisme hypogonadotrophique --- r_associated #0: 185 --> en:c-cell hyperplasia
    n1=hypogonadisme hypogonadotrophique | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=185
  8. en:hypogonadotropic hypogonadism --- r_associated #0: 182 --> en:c-cell hyperplasia
    n1=en:hypogonadotropic hypogonadism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=182
  9. atrophie congénitale de la thyroïde --- r_associated #0: 181 --> en:c-cell hyperplasia
    n1=atrophie congénitale de la thyroïde | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=181
  10. hyperandrogénisme --- r_associated #0: 181 --> en:c-cell hyperplasia
    n1=hyperandrogénisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=181
  11. en:androgen excess --- r_associated #0: 180 --> en:c-cell hyperplasia
    n1=en:androgen excess | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=180
  12. en:hyperandrogenism --- r_associated #0: 180 --> en:c-cell hyperplasia
    n1=en:hyperandrogenism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=180
  13. hypothyroïdisme congénital --- r_associated #0: 180 --> en:c-cell hyperplasia
    n1=hypothyroïdisme congénital | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=180
  14. en:congenital atrophy of thyroid --- r_associated #0: 175 --> en:c-cell hyperplasia
    n1=en:congenital atrophy of thyroid | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=175
  15. hyperandrogénie --- r_associated #0: 175 --> en:c-cell hyperplasia
    n1=hyperandrogénie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=175
  16. crétinismes --- r_associated #0: 170 --> en:c-cell hyperplasia
    n1=crétinismes | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=170
  17. en:congenital hypothyroidism --- r_associated #0: 165 --> en:c-cell hyperplasia
    n1=en:congenital hypothyroidism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=165
  18. hypo-aldostéronisme --- r_associated #0: 146 --> en:c-cell hyperplasia
    n1=hypo-aldostéronisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=146
  19. hypoaldostéronisme --- r_associated #0: 145 --> en:c-cell hyperplasia
    n1=hypoaldostéronisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=145
  20. en:hypoaldosteronemia --- r_associated #0: 143 --> en:c-cell hyperplasia
    n1=en:hypoaldosteronemia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=143
  21. en:hypoaldosteronism --- r_associated #0: 140 --> en:c-cell hyperplasia
    n1=en:hypoaldosteronism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=140
  22. tumeur bénigne prostatique --- r_associated #0: 138 --> en:c-cell hyperplasia
    n1=tumeur bénigne prostatique | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=138
  23. en:benign prostate neoplasm --- r_associated #0: 136 --> en:c-cell hyperplasia
    n1=en:benign prostate neoplasm | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=136
  24. adénome de la prostate --- r_associated #0: 133 --> en:c-cell hyperplasia
    n1=adénome de la prostate | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=133
  25. tumeur bénigne de la prostate --- r_associated #0: 131 --> en:c-cell hyperplasia
    n1=tumeur bénigne de la prostate | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=131
  26. kyste du canal thyroglossal --- r_associated #0: 125 --> en:c-cell hyperplasia
    n1=kyste du canal thyroglossal | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=125
  27. en:benign neoplasm of prostate --- r_associated #0: 124 --> en:c-cell hyperplasia
    n1=en:benign neoplasm of prostate | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=124
  28. infertilité féminine --- r_associated #0: 121 --> en:c-cell hyperplasia
    n1=infertilité féminine | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=121
  29. en:thyroglossal duct cyst --- r_associated #0: 119 --> en:c-cell hyperplasia
    n1=en:thyroglossal duct cyst | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=119
  30. hypertrophie bénigne de la prostate --- r_associated #0: 117 --> en:c-cell hyperplasia
    n1=hypertrophie bénigne de la prostate | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=117
  31. kyste du canal thyréoglosse --- r_associated #0: 115 --> en:c-cell hyperplasia
    n1=kyste du canal thyréoglosse | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=115
  32. en:female infertility --- r_associated #0: 112 --> en:c-cell hyperplasia
    n1=en:female infertility | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=112
  33. kyste thyréoglosse --- r_associated #0: 111 --> en:c-cell hyperplasia
    n1=kyste thyréoglosse | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=111
  34. stérilité féminine --- r_associated #0: 111 --> en:c-cell hyperplasia
    n1=stérilité féminine | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=111
  35. adénome prostatique --- r_associated #0: 110 --> en:c-cell hyperplasia
    n1=adénome prostatique | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=110
  36. en:prostate adenoma --- r_associated #0: 110 --> en:c-cell hyperplasia
    n1=en:prostate adenoma | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=110
  37. infertilité de la femme --- r_associated #0: 107 --> en:c-cell hyperplasia
    n1=infertilité de la femme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=107
  38. kyste du tractus thyréoglosse --- r_associated #0: 105 --> en:c-cell hyperplasia
    n1=kyste du tractus thyréoglosse | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=105
  39. puberté retardée --- r_associated #0: 100 --> en:c-cell hyperplasia
    n1=puberté retardée | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=100
  40. puberté rétardée --- r_associated #0: 100 --> en:c-cell hyperplasia
    n1=puberté rétardée | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=100
  41. en:delayed puberty --- r_associated #0: 96 --> en:c-cell hyperplasia
    n1=en:delayed puberty | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=96
  42. hyperaldostéronisme --- r_associated #0: 95 --> en:c-cell hyperplasia
    n1=hyperaldostéronisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=95
  43. hyperplasie congénitale des surrénales --- r_associated #0: 95 --> en:c-cell hyperplasia
    n1=hyperplasie congénitale des surrénales | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=95
  44. en:congenital adrenal hyperplasia --- r_associated #0: 94 --> en:c-cell hyperplasia
    n1=en:congenital adrenal hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=94
  45. en:hyperaldosteronism --- r_associated #0: 91 --> en:c-cell hyperplasia
    n1=en:hyperaldosteronism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=91
  46. puberté tardive --- r_associated #0: 86 --> en:c-cell hyperplasia
    n1=puberté tardive | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=86
  47. hypopituitarisme --- r_associated #0: 85 --> en:c-cell hyperplasia
    n1=hypopituitarisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=85
  48. hypothyroïdisme --- r_associated #0: 84 --> en:c-cell hyperplasia
    n1=hypothyroïdisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=84
  49. déficit en hormone de croissance --- r_associated #0: 81 --> en:c-cell hyperplasia
    n1=déficit en hormone de croissance | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=81
  50. en:hypopituitarism --- r_associated #0: 81 --> en:c-cell hyperplasia
    n1=en:hypopituitarism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=81
  51. en:growth hormone deficiency --- r_associated #0: 80 --> en:c-cell hyperplasia
    n1=en:growth hormone deficiency | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=80
  52. en:hypothyroidism --- r_associated #0: 80 --> en:c-cell hyperplasia
    n1=en:hypothyroidism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=80
  53. panhypopituitarisme --- r_associated #0: 71 --> en:c-cell hyperplasia
    n1=panhypopituitarisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=71
  54. en:Klinefelter syndrome --- r_associated #0: 70 --> en:c-cell hyperplasia
    n1=en:Klinefelter syndrome | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=70
  55. en:klinefelter syndrome --- r_associated #0: 68 --> en:c-cell hyperplasia
    n1=en:klinefelter syndrome | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=68
  56. en:panhypopituitarism --- r_associated #0: 68 --> en:c-cell hyperplasia
    n1=en:panhypopituitarism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=68
  57. hypothyroïdie --- r_associated #0: 64 --> en:c-cell hyperplasia
    n1=hypothyroïdie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=64
  58. maladie d'addison --- r_associated #0: 63 --> en:c-cell hyperplasia
    n1=maladie d'addison | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=63
  59. corps thyroïde --- r_associated #0: 62 --> en:c-cell hyperplasia
    n1=corps thyroïde | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=62
  60. en:addison disease --- r_associated #0: 62 --> en:c-cell hyperplasia
    n1=en:addison disease | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=62
  61. glande thyroïde --- r_associated #0: 61 --> en:c-cell hyperplasia
    n1=glande thyroïde | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=61
  62. en:thyroid gland --- r_associated #0: 60 --> en:c-cell hyperplasia
    n1=en:thyroid gland | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=60
  63. pseudo-hypoparathyroïdie --- r_associated #0: 60 --> en:c-cell hyperplasia
    n1=pseudo-hypoparathyroïdie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=60
  64. pseudo-hypoparathyroïdisme --- r_associated #0: 60 --> en:c-cell hyperplasia
    n1=pseudo-hypoparathyroïdisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=60
  65. maladie d'Addison --- r_associated #0: 59 --> en:c-cell hyperplasia
    n1=maladie d'Addison | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=59
  66. pseudohypoparathyroïdie --- r_associated #0: 58 --> en:c-cell hyperplasia
    n1=pseudohypoparathyroïdie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=58
  67. en:Addison's disease --- r_associated #0: 56 --> en:c-cell hyperplasia
    n1=en:Addison's disease | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=56
  68. hyperthyroïdie --- r_associated #0: 56 --> en:c-cell hyperplasia
    n1=hyperthyroïdie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=56
  69. pseudohypoparathyroïdisme --- r_associated #0: 56 --> en:c-cell hyperplasia
    n1=pseudohypoparathyroïdisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=56
  70. en:hyperthyroidism --- r_associated #0: 55 --> en:c-cell hyperplasia
    n1=en:hyperthyroidism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=55
  71. en:pseudohypoparathyroidism --- r_associated #0: 55 --> en:c-cell hyperplasia
    n1=en:pseudohypoparathyroidism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=55
  72. en:thyroid body --- r_associated #0: 55 --> en:c-cell hyperplasia
    n1=en:thyroid body | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=55
  73. hyperthyroïdisme --- r_associated #0: 55 --> en:c-cell hyperplasia
    n1=hyperthyroïdisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=55
  74. Glande thyroïde --- r_associated #0: 54 --> en:c-cell hyperplasia
    n1=Glande thyroïde | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=54
  75. en:addison's disease --- r_associated #0: 52 --> en:c-cell hyperplasia
    n1=en:addison's disease | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=52
  76. hyperplasie bénigne de la prostate --- r_associated #0: 50 --> en:c-cell hyperplasia
    n1=hyperplasie bénigne de la prostate | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=50
  77. en:benign prostatic hyperplasia --- r_associated #0: 49 --> en:c-cell hyperplasia
    n1=en:benign prostatic hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=49
  78. insuffisance surrénalienne chronique primaire --- r_associated #0: 49 --> en:c-cell hyperplasia
    n1=insuffisance surrénalienne chronique primaire | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=49
  79. acromégalie --- r_associated #0: 47 --> en:c-cell hyperplasia
    n1=acromégalie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=47
  80. en:acromegaly --- r_associated #0: 47 --> en:c-cell hyperplasia
    n1=en:acromegaly | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=47
  81. puberté précoce --- r_associated #0: 47 --> en:c-cell hyperplasia
    n1=puberté précoce | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=47
  82. en:acanthosis --- r_associated #0: 46 --> en:c-cell hyperplasia
    n1=en:acanthosis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=46
  83. Puberté précoce --- r_associated #0: 45 --> en:c-cell hyperplasia
    n1=Puberté précoce | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=45
  84. acromegaly --- r_associated #0: 45 --> en:c-cell hyperplasia
    n1=acromegaly | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=45
  85. en:hyperkeratosis --- r_associated #0: 45 --> en:c-cell hyperplasia
    n1=en:hyperkeratosis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=45
  86. en:precocious puberty --- r_associated #0: 44 --> en:c-cell hyperplasia
    n1=en:precocious puberty | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=44
  87. hamartoblastome hypothalamique, hypopituitarisme, imperforation anale et polydactylie post-axiale --- r_associated #0: 44 --> en:c-cell hyperplasia
    n1=hamartoblastome hypothalamique, hypopituitarisme, imperforation anale et polydactylie post-axiale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=44
  88. hypercalcémie --- r_associated #0: 44 --> en:c-cell hyperplasia
    n1=hypercalcémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=44
  89. hyperplasie prostatique bénigne --- r_associated #0: 44 --> en:c-cell hyperplasia
    n1=hyperplasie prostatique bénigne | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=44
  90. acanthosis --- r_associated #0: 43 --> en:c-cell hyperplasia
    n1=acanthosis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=43
  91. en:hypocalcemia --- r_associated #0: 43 --> en:c-cell hyperplasia
    n1=en:hypocalcemia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=43
  92. en:denture-induced fibrous hyperplasia --- r_associated #0: 42 --> en:c-cell hyperplasia
    n1=en:denture-induced fibrous hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=42
  93. en:hypercalcemia --- r_associated #0: 42 --> en:c-cell hyperplasia
    n1=en:hypercalcemia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=42
  94. tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial --- r_associated #0: 42 --> en:c-cell hyperplasia
    n1=tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=42
  95. en:multiple endocrine neoplasia type 2b --- r_associated #0: 41 --> en:c-cell hyperplasia
    n1=en:multiple endocrine neoplasia type 2b | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=41
  96. hyperkeratosis --- r_associated #0: 41 --> en:c-cell hyperplasia
    n1=hyperkeratosis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=41
  97. retard pubertaire --- r_associated #0: 41 --> en:c-cell hyperplasia
    n1=retard pubertaire | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=41
  98. en:Addison disease --- r_associated #0: 40 --> en:c-cell hyperplasia
    n1=en:Addison disease | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=40
  99. en:abnormal glucose tolerance test --- r_associated #0: 40 --> en:c-cell hyperplasia
    n1=en:abnormal glucose tolerance test | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=40
  100. en:diabetes mellitus --- r_associated #0: 40 --> en:c-cell hyperplasia
    n1=en:diabetes mellitus | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=40
  101. en:hypogonadotrophic hypogonadism --- r_associated #0: 40 --> en:c-cell hyperplasia
    n1=en:hypogonadotrophic hypogonadism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=40
  102. goitre multinodulaire --- r_associated #0: 40 --> en:c-cell hyperplasia
    n1=goitre multinodulaire | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=40
  103. hyperkératose --- r_associated #0: 40 --> en:c-cell hyperplasia
    n1=hyperkératose | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=40
  104. thyroïdite --- r_associated #0: 40 --> en:c-cell hyperplasia
    n1=thyroïdite | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=40
  105. en:renal tubulopathy --- r_associated #0: 39 --> en:c-cell hyperplasia
    n1=en:renal tubulopathy | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=39
  106. hyperplasie sébacée --- r_associated #0: 39 --> en:c-cell hyperplasia
    n1=hyperplasie sébacée | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=39
  107. hypostimulinie --- r_associated #0: 39 --> en:c-cell hyperplasia
    n1=hypostimulinie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=39
  108. diabète sucré de type 2 avec surdité --- r_associated #0: 38 --> en:c-cell hyperplasia
    n1=diabète sucré de type 2 avec surdité | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=38
  109. diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale --- r_associated #0: 38 --> en:c-cell hyperplasia
    n1=diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=38
  110. hypoplasie des ailes du nez-hypothyroïdisme-absence de sécrétion pancréatique-surdité congénitale --- r_associated #0: 38 --> en:c-cell hyperplasia
    n1=hypoplasie des ailes du nez-hypothyroïdisme-absence de sécrétion pancréatique-surdité congénitale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=38
  111. en:hashimoto thyroiditis --- r_associated #0: 37 --> en:c-cell hyperplasia
    n1=en:hashimoto thyroiditis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=37
  112. en:low serum igf2 levels --- r_associated #0: 37 --> en:c-cell hyperplasia
    n1=en:low serum igf2 levels | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=37
  113. en:multinodular goiter --- r_associated #0: 37 --> en:c-cell hyperplasia
    n1=en:multinodular goiter | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=37
  114. en:thyroglossal cyst --- r_associated #0: 37 --> en:c-cell hyperplasia
    n1=en:thyroglossal cyst | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=37
  115. en:thyroid gland abscess --- r_associated #0: 37 --> en:c-cell hyperplasia
    n1=en:thyroid gland abscess | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=37
  116. en:thyroiditis --- r_associated #0: 37 --> en:c-cell hyperplasia
    n1=en:thyroiditis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=37
  117. en:enlarged adrenal gland --- r_associated #0: 36 --> en:c-cell hyperplasia
    n1=en:enlarged adrenal gland | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=36
  118. en:hypothyroidy --- r_associated #0: 36 --> en:c-cell hyperplasia
    n1=en:hypothyroidy | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=36
  119. en:other nontoxic goitre --- r_associated #0: 36 --> en:c-cell hyperplasia
    n1=en:other nontoxic goitre | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=36
  120. en:overactive thyroid --- r_associated #0: 36 --> en:c-cell hyperplasia
    n1=en:overactive thyroid | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=36
  121. en:sebaceous hyperplasia --- r_associated #0: 36 --> en:c-cell hyperplasia
    n1=en:sebaceous hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=36
  122. thyréoïdite --- r_associated #0: 36 --> en:c-cell hyperplasia
    n1=thyréoïdite | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=36
  123. Corps thyroïde --- r_associated #0: 35 --> en:c-cell hyperplasia
    n1=Corps thyroïde | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=35
  124. en:decreased circulating renin level --- r_associated #0: 35 --> en:c-cell hyperplasia
    n1=en:decreased circulating renin level | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=35
  125. en:focal epithelial hyperplasia --- r_associated #0: 35 --> en:c-cell hyperplasia
    n1=en:focal epithelial hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=35
  126. en:glandular and stromal hyperplasia --- r_associated #0: 35 --> en:c-cell hyperplasia
    n1=en:glandular and stromal hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=35
  127. en:hypoglycemia, fasting --- r_associated #0: 35 --> en:c-cell hyperplasia
    n1=en:hypoglycemia, fasting | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=35
  128. en:hypoinsulinaemia (disorder) --- r_associated #0: 35 --> en:c-cell hyperplasia
    n1=en:hypoinsulinaemia (disorder) | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=35
  129. en:mass of thyroid gland --- r_associated #0: 35 --> en:c-cell hyperplasia
    n1=en:mass of thyroid gland | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=35
  130. en:pain in thyroid --- r_associated #0: 35 --> en:c-cell hyperplasia
    n1=en:pain in thyroid | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=35
  131. en:perinatal thyroid disorder --- r_associated #0: 35 --> en:c-cell hyperplasia
    n1=en:perinatal thyroid disorder | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=35
  132. en:reactive hypoglycemia --- r_associated #0: 35 --> en:c-cell hyperplasia
    n1=en:reactive hypoglycemia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=35
  133. en:thyroid gland follicular adenoma --- r_associated #0: 35 --> en:c-cell hyperplasia
    n1=en:thyroid gland follicular adenoma | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=35
  134. en:autoimmune thyroiditis --- r_associated #0: 34 --> en:c-cell hyperplasia
    n1=en:autoimmune thyroiditis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=34
  135. en:diffuse c-cell hyperplasia --- r_associated #0: 34 --> en:c-cell hyperplasia
    n1=en:diffuse c-cell hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=34
  136. en:glucagonoma syndrome --- r_associated #0: 34 --> en:c-cell hyperplasia
    n1=en:glucagonoma syndrome | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=34
  137. en:gonadotrophin increased --- r_associated #0: 34 --> en:c-cell hyperplasia
    n1=en:gonadotrophin increased | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=34
  138. en:hyperinsulinemic hypoglycemia --- r_associated #0: 34 --> en:c-cell hyperplasia
    n1=en:hyperinsulinemic hypoglycemia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=34
  139. en:normal basal plasma cortisol --- r_associated #0: 34 --> en:c-cell hyperplasia
    n1=en:normal basal plasma cortisol | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=34
  140. en:pituitary hormone deficiency --- r_associated #0: 34 --> en:c-cell hyperplasia
    n1=en:pituitary hormone deficiency | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=34
  141. en:thyroid calcification --- r_associated #0: 34 --> en:c-cell hyperplasia
    n1=en:thyroid calcification | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=34
  142. en:thyroid dysfunction --- r_associated #0: 34 --> en:c-cell hyperplasia
    n1=en:thyroid dysfunction | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=34
  143. glucagonome (syndrome du) --- r_associated #0: 34 --> en:c-cell hyperplasia
    n1=glucagonome (syndrome du) | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=34
  144. hyperacanthose --- r_associated #0: 34 --> en:c-cell hyperplasia
    n1=hyperacanthose | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=34
  145. retard de la puberté --- r_associated #0: 33 --> en:c-cell hyperplasia
    n1=retard de la puberté | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=33
  146. en:adrenal hyperplasia, bilateral --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:adrenal hyperplasia, bilateral | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  147. en:c-cell --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:c-cell | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  148. en:congenital absence of thymus --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:congenital absence of thymus | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  149. en:cushing disease --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:cushing disease | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  150. en:decreased testosterone level --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:decreased testosterone level | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  151. en:delayed puberty (in most patients) --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:delayed puberty (in most patients) | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  152. en:euthyroid (finding) --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:euthyroid (finding) | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  153. en:lymphoid hyperplasia --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:lymphoid hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  154. en:multiple endocrine neoplasia type 2a --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:multiple endocrine neoplasia type 2a | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  155. en:normal pituitary function --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:normal pituitary function | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  156. en:premature thelarche --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:premature thelarche | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  157. en:reticuloendothelial hyperplasia --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:reticuloendothelial hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  158. en:secondary adrenal insufficiency --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:secondary adrenal insufficiency | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  159. en:secondary hyperparathyroidism --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:secondary hyperparathyroidism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  160. en:sick euthyroid syndrome --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:sick euthyroid syndrome | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  161. en:syndrome of inappropriate antidiuretic hormone secretion --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:syndrome of inappropriate antidiuretic hormone secretion | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  162. en:thyroid hormone binding abnormality --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=en:thyroid hormone binding abnormality | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  163. encéphalopathie avec calcification intracrânienne, déficience en hormone de croissance, microcéphalie et dégénérescence rétinienne --- r_associated #0: 32 --> en:c-cell hyperplasia
    n1=encéphalopathie avec calcification intracrânienne, déficience en hormone de croissance, microcéphalie et dégénérescence rétinienne | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=32
  164. en:elevated gonadotropin levels --- r_associated #0: 31 --> en:c-cell hyperplasia
    n1=en:elevated gonadotropin levels | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=31
  165. en:glandula thyroidea --- r_associated #0: 31 --> en:c-cell hyperplasia
    n1=en:glandula thyroidea | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=31
  166. en:hyperplastic tissue present --- r_associated #0: 31 --> en:c-cell hyperplasia
    n1=en:hyperplastic tissue present | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=31
  167. en:hypothyreosis --- r_associated #0: 31 --> en:c-cell hyperplasia
    n1=en:hypothyreosis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=31
  168. en:injury of thyroid gland --- r_associated #0: 31 --> en:c-cell hyperplasia
    n1=en:injury of thyroid gland | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=31
  169. en:multiple endocrine neoplasia type 2A --- r_associated #0: 31 --> en:c-cell hyperplasia
    n1=en:multiple endocrine neoplasia type 2A | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=31
  170. en:neonatal hypothyroidism --- r_associated #0: 31 --> en:c-cell hyperplasia
    n1=en:neonatal hypothyroidism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=31
  171. hyperplasie épithéliale focale de Heck --- r_associated #0: 31 --> en:c-cell hyperplasia
    n1=hyperplasie épithéliale focale de Heck | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=31
  172. hypoglycémie du nouveau-né --- r_associated #0: 31 --> en:c-cell hyperplasia
    n1=hypoglycémie du nouveau-né | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=31
  173. hypohypophysie --- r_associated #0: 31 --> en:c-cell hyperplasia
    n1=hypohypophysie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=31
  174. thyroidite --- r_associated #0: 31 --> en:c-cell hyperplasia
    n1=thyroidite | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=31
  175. diabète (accidents vasculaires cérébraux du) --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=diabète (accidents vasculaires cérébraux du) | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  176. diabète sucré --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=diabète sucré | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  177. en:adrenal hyperplasia --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:adrenal hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  178. en:aldosterone level increased above normal --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:aldosterone level increased above normal | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  179. en:benign prostate hypertrophy --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:benign prostate hypertrophy | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  180. en:connective tissue hyperplasia --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:connective tissue hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  181. en:elevated fasting plasma glucose --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:elevated fasting plasma glucose | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  182. en:focal nodular hyperplasia --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:focal nodular hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  183. en:haemorrhagic thyroid cyst --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:haemorrhagic thyroid cyst | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  184. en:hypernatremia --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:hypernatremia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  185. en:infarction of thyroid --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:infarction of thyroid | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  186. en:nasal alar hypoplasia --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:nasal alar hypoplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  187. en:neonatal diabetes mellitus --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:neonatal diabetes mellitus | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  188. en:pachyderma --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:pachyderma | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  189. en:pituitary dwarfism --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:pituitary dwarfism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  190. en:stein-leventhal syndrome --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:stein-leventhal syndrome | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  191. en:sugar diabetes --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:sugar diabetes | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  192. en:thyroid gland papillary carcinoma --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=en:thyroid gland papillary carcinoma | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  193. pachydermie --- r_associated #0: 30 --> en:c-cell hyperplasia
    n1=pachydermie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=30
  194. en:adrenal agenesis/dysgenesis --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:adrenal agenesis/dysgenesis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  195. en:benign overgrowth of the prostate --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:benign overgrowth of the prostate | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  196. en:c-cell hyperplasia multifocal --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:c-cell hyperplasia multifocal | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  197. en:congenital hypoplasia of thymus --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:congenital hypoplasia of thymus | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  198. en:cushing syndrome --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:cushing syndrome | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  199. en:elevated fasting glucose --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:elevated fasting glucose | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  200. en:epidermal hyperplasia --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:epidermal hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  201. en:hypernatraemia --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:hypernatraemia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  202. en:inherited disorder of thyroid metabolism --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:inherited disorder of thyroid metabolism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  203. en:intraductal hyperplasia --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:intraductal hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  204. en:maturity-onset diabetes of the young --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:maturity-onset diabetes of the young | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  205. en:thyroid cyst --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:thyroid cyst | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  206. en:thyroid disorders nec --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:thyroid disorders nec | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  207. en:thyroid hyperplasia --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:thyroid hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  208. en:uroglycosis --- r_associated #0: 29 --> en:c-cell hyperplasia
    n1=en:uroglycosis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=29
  209. en:adenomyomatosis --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:adenomyomatosis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  210. en:adrenal cortex adenoma --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:adrenal cortex adenoma | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  211. en:adrenal hypoplasia --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:adrenal hypoplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  212. en:and cerebellar ataxia due to duplication of mitochondrial DNA --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:and cerebellar ataxia due to duplication of mitochondrial DNA | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  213. en:congenital absence of parathyroid gland --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:congenital absence of parathyroid gland | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  214. en:congenital anomaly of the thyroid gland --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:congenital anomaly of the thyroid gland | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  215. en:elevated baseline 17-hydroxypregnenolone levels --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:elevated baseline 17-hydroxypregnenolone levels | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  216. en:encephalopathy with intracranial calcification --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:encephalopathy with intracranial calcification | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  217. en:head and neck --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:head and neck | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  218. en:hypercortisolemia --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:hypercortisolemia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  219. en:infertilitas feminis --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:infertilitas feminis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  220. en:iodine-deficiency-related thyroid disorders and allied conditions --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:iodine-deficiency-related thyroid disorders and allied conditions | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  221. en:nodular hyperplasia --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:nodular hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  222. en:thyroid dysfunction of mother, antepartum condition or complication --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:thyroid dysfunction of mother, antepartum condition or complication | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  223. en:thyroid gland follicle --- r_associated #0: 28 --> en:c-cell hyperplasia
    n1=en:thyroid gland follicle | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=28
  224. en:absent anti-mullerian hormone --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:absent anti-mullerian hormone | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  225. en:adrenal gland hyperplasia --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:adrenal gland hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  226. en:basosquamous acanthoma --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:basosquamous acanthoma | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  227. en:benign prostatic hypertrophy --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:benign prostatic hypertrophy | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  228. en:bone marrow hyperplasia --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:bone marrow hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  229. en:cervical neuroendocrine carcinoma --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:cervical neuroendocrine carcinoma | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  230. en:congenital absence of adrenal gland --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:congenital absence of adrenal gland | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  231. en:drug induced gingival hyperplasia --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:drug induced gingival hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  232. en:ectopic thyroid gland --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:ectopic thyroid gland | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  233. en:hyperandrogeny --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:hyperandrogeny | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  234. en:hypothalamic hamartoblastoma --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:hypothalamic hamartoblastoma | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  235. en:islets of langerhans hyperplasia --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:islets of langerhans hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  236. en:neonatal hypoglycemia --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:neonatal hypoglycemia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  237. en:neuroendocrine cell hyperplasia of infancy --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:neuroendocrine cell hyperplasia of infancy | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  238. en:skin hyperplasia --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:skin hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  239. en:thyroid dysgenesis --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:thyroid dysgenesis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  240. en:thyroid function normal --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:thyroid function normal | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  241. en:thyrotoxicosis [hyperthyroidism] --- r_associated #0: 27 --> en:c-cell hyperplasia
    n1=en:thyrotoxicosis [hyperthyroidism] | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=27
  242. asynergie oculo-palpébrale --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=asynergie oculo-palpébrale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  243. en:Heck's disease --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=en:Heck's disease | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  244. en:atypical hyperplasia --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=en:atypical hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  245. en:congenital adrenal gland hypoplasia --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=en:congenital adrenal gland hypoplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  246. en:congenital iodine deficiency hypothyroidism --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=en:congenital iodine deficiency hypothyroidism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  247. en:focal hyperplasia --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=en:focal hyperplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  248. en:hyperprolactinemia --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=en:hyperprolactinemia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  249. en:lid lag --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=en:lid lag | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  250. en:low to normal estradiol levels --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=en:low to normal estradiol levels | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  251. en:normal serum igfbp3 levels --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=en:normal serum igfbp3 levels | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  252. en:parathyroid gland adenoma --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=en:parathyroid gland adenoma | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  253. en:persistent thyroglossal duct --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=en:persistent thyroglossal duct | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  254. en:primary hypothyroidism --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=en:primary hypothyroidism | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  255. en:prostatic adenoma --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=en:prostatic adenoma | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  256. en:thyroid oncocytic metaplasia --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=en:thyroid oncocytic metaplasia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  257. hyperplasie atypique --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=hyperplasie atypique | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  258. hypocalcémie --- r_associated #0: 26 --> en:c-cell hyperplasia
    n1=hypocalcémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=26
  259. en:neck --- r_associated #0: 25 --> en:c-cell hyperplasia
    n1=en:neck | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=25
  260. hyodésoxycholique (acide) --- r_associated #0: 25 --> en:c-cell hyperplasia
    n1=hyodésoxycholique (acide) | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=25
  261. acromégalie, plis cutanés de la face et du cuir chevelu, et leucomes cornéens --- r_associated #0: 24 --> en:c-cell hyperplasia
    n1=acromégalie, plis cutanés de la face et du cuir chevelu, et leucomes cornéens | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=24
  262. en:hypercalcaemia --- r_associated #0: 24 --> en:c-cell hyperplasia
    n1=en:hypercalcaemia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=24
  263. en:prostatic hypertrophy --- r_associated #0: 24 --> en:c-cell hyperplasia
    n1=en:prostatic hypertrophy | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=24
  264. en:urophtisis --- r_associated #0: 23 --> en:c-cell hyperplasia
    n1=en:urophtisis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=23
  265. hypoactivité de l'hypophyse --- r_associated #0: 23 --> en:c-cell hyperplasia
    n1=hypoactivité de l'hypophyse | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=23
  266. en:Stein-Leventhal syndrome --- r_associated #0: 22 --> en:c-cell hyperplasia
    n1=en:Stein-Leventhal syndrome | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=22
  267. en:photomyoclonus --- r_associated #0: 22 --> en:c-cell hyperplasia
    n1=en:photomyoclonus | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=22
  268. acanthose --- r_associated #0: 21 --> en:c-cell hyperplasia
    n1=acanthose | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=21
  269. asynergie oculopalpébrale --- r_associated #0: 21 --> en:c-cell hyperplasia
    n1=asynergie oculopalpébrale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=21
  270. déficit enzymatique partiel de la surrénale --- r_associated #0: 21 --> en:c-cell hyperplasia
    n1=déficit enzymatique partiel de la surrénale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=21
  271. en:acyesis --- r_associated #0: 21 --> en:c-cell hyperplasia
    n1=en:acyesis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=21
  272. hypernatrémie --- r_associated #0: 21 --> en:c-cell hyperplasia
    n1=hypernatrémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=21
  273. Adénome prostatique --- r_associated #0: 20 --> en:c-cell hyperplasia
    n1=Adénome prostatique | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=20
  274. Thyroïdite --- r_associated #0: 20 --> en:c-cell hyperplasia
    n1=Thyroïdite | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=20
  275. Diabète sucré --- r_associated #0: 15 --> en:c-cell hyperplasia
    n1=Diabète sucré | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=15
  276. Goerttler (théorie de) --- r_associated #0: 15 --> en:c-cell hyperplasia
    n1=Goerttler (théorie de) | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=15
  277. Hyperplasie congénitale des surrénales --- r_associated #0: 15 --> en:c-cell hyperplasia
    n1=Hyperplasie congénitale des surrénales | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=15
  278. Hypertrophie bénigne de la prostate --- r_associated #0: 15 --> en:c-cell hyperplasia
    n1=Hypertrophie bénigne de la prostate | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=15
  279. Infertilité féminine --- r_associated #0: 15 --> en:c-cell hyperplasia
    n1=Infertilité féminine | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=15
  280. Maladie d'Addison --- r_associated #0: 15 --> en:c-cell hyperplasia
    n1=Maladie d'Addison | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=15
  281. crétinisme --- r_associated #0: 15 --> en:c-cell hyperplasia
    n1=crétinisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=15
  282. en:hypocalcaemia --- r_associated #0: 15 --> en:c-cell hyperplasia
    n1=en:hypocalcaemia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=15
  283. hypermobilité articulaire (syndrome d') --- r_associated #0: 15 --> en:c-cell hyperplasia
    n1=hypermobilité articulaire (syndrome d') | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=15
  284. hypothyroïdie (manifestations neuromusculaires dans l') --- r_associated #0: 15 --> en:c-cell hyperplasia
    n1=hypothyroïdie (manifestations neuromusculaires dans l') | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=15
  285. hypothyroïdie néonatale --- r_associated #0: 11 --> en:c-cell hyperplasia
    n1=hypothyroïdie néonatale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=11
  286. Acromégalie --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=Acromégalie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  287. Déficit en hormone de croissance --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=Déficit en hormone de croissance | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  288. Haltia-Santavuori (maladie de) --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=Haltia-Santavuori (maladie de) | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  289. Hyperaldostéronisme --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=Hyperaldostéronisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  290. Hypercalcémie --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=Hypercalcémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  291. Hypernatrémie --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=Hypernatrémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  292. Hyperthyroïdie --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=Hyperthyroïdie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  293. Hypocalcémie --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=Hypocalcémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  294. Hypopituitarisme --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=Hypopituitarisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  295. Hypothyroïdie --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=Hypothyroïdie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  296. Pachon (appareil de) --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=Pachon (appareil de) | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  297. Puberté tardive --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=Puberté tardive | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  298. diabète non-insulinodépendant --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=diabète non-insulinodépendant | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  299. diabète phosphaté --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=diabète phosphaté | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  300. diabète post-transplantation --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=diabète post-transplantation | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  301. diabète rénal --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=diabète rénal | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  302. en:Goerttler's theory --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:Goerttler's theory | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  303. en:acanthokeratodermia --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:acanthokeratodermia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  304. en:acromegalia --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:acromegalia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  305. en:and cerebral dysfonction --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:and cerebral dysfonction | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  306. en:and congenital deafness --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:and congenital deafness | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  307. en:and postaxil polydactylie --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:and postaxil polydactylie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  308. en:and retinal degeneration --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:and retinal degeneration | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  309. en:deafness --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:deafness | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  310. en:diabetic strokes --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:diabetic strokes | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  311. en:enlargement of the prostate gland --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:enlargement of the prostate gland | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  312. en:hyodeoxycholic acid --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:hyodeoxycholic acid | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  313. en:hyperacanthosis --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:hyperacanthosis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  314. en:imperforate anus --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:imperforate anus | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  315. en:microcephaly --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:microcephaly | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  316. en:necrolytic migratory erythema --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:necrolytic migratory erythema | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  317. en:nephropathy --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:nephropathy | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  318. en:pancreatic achylia --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:pancreatic achylia | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  319. en:periurethral adenoma --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:periurethral adenoma | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  320. en:thyroadenitis --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:thyroadenitis | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  321. en:type II --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:type II | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  322. en:with deafness --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=en:with deafness | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  323. glucane --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=glucane | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  324. glucidase --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=glucidase | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  325. glucide --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=glucide | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  326. hyperintense (signal IRM) --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=hyperintense (signal IRM) | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  327. hypothyroïdie et psychisme --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=hypothyroïdie et psychisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  328. néoplasie endocrinienne multiple de type 2A (MEN 2A) --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=néoplasie endocrinienne multiple de type 2A (MEN 2A) | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  329. syndrome de Stein-Leventhal-Cohen --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=syndrome de Stein-Leventhal-Cohen | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  330. thyroïdien (cancer) --- r_associated #0: 10 --> en:c-cell hyperplasia
    n1=thyroïdien (cancer) | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=10
  331. Addison (maladie d') --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=Addison (maladie d') | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  332. Hyper-HDLémie --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=Hyper-HDLémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  333. Hyperkératose --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=Hyperkératose | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  334. absence d'hormone antimüllérienne --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=absence d'hormone antimüllérienne | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  335. diabète bronzé --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabète bronzé | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  336. diabète de type 1 --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabète de type 1 | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  337. diabète de type 2 --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabète de type 2 | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  338. diabète et psychisme --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabète et psychisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  339. diabète et surdité d'origine mitochondriale --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabète et surdité d'origine mitochondriale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  340. diabète gestationnel --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabète gestationnel | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  341. diabète gras --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabète gras | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  342. diabète insipide --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabète insipide | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  343. diabète insipide néphrogénique --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabète insipide néphrogénique | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  344. diabète insulino-requérant --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabète insulino-requérant | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  345. diabète insulinodépendant --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabète insulinodépendant | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  346. diabète lipoatrophique congénital --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabète lipoatrophique congénital | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  347. diabète sucré et complications rénales --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabète sucré et complications rénales | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  348. diabètes monogéniques --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabètes monogéniques | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  349. diabètes sucrés et insipides avec atrophie optique et surdité --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabètes sucrés et insipides avec atrophie optique et surdité | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  350. diabétide génitale --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=diabétide génitale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  351. hyoïdien --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyoïdien | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  352. hyper-LDLémie --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyper-LDLémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  353. hyper-alpha-globulinémie --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyper-alpha-globulinémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  354. hyper-bêta-alaninémie --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyper-bêta-alaninémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  355. hyper-bêta-globulinémie --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyper-bêta-globulinémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  356. hyper-bêta-lipoprotéinémie --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyper-bêta-lipoprotéinémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  357. hyperabsorbant --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyperabsorbant | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  358. hyperaction d'un muscle oculomoteur --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyperaction d'un muscle oculomoteur | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  359. hyperactivité avec déficit de l'attention --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyperactivité avec déficit de l'attention | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  360. hyperactivité détrusorienne --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyperactivité détrusorienne | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  361. hyperactivité vésicale --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyperactivité vésicale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  362. hyperalaninémie --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyperalaninémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  363. hyperaldostéronisme primaire --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyperaldostéronisme primaire | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  364. hyperaldostéronisme secondaire --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyperaldostéronisme secondaire | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  365. hyperaminoacidurie --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyperaminoacidurie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  366. hyperaminoacidémie --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyperaminoacidémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  367. hyperammoniémie --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyperammoniémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  368. hyperammoniémie congénitale --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hyperammoniémie congénitale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  369. hypotonie plasmatique --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hypotonie plasmatique | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  370. hypotonie sphinctérienne anale --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hypotonie sphinctérienne anale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  371. hypotonie sphinctérienne uréthrale --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hypotonie sphinctérienne uréthrale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  372. hypotonie utérine --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hypotonie utérine | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  373. hypotonie vésicale --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hypotonie vésicale | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  374. hypotonie, obésité et incisives proéminentes --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hypotonie, obésité et incisives proéminentes | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  375. hypotonique --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hypotonique | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  376. hypotrichose --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hypotrichose | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  377. hypotrichose avec anodontie et anhidrose de Touraine --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hypotrichose avec anodontie et anhidrose de Touraine | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  378. hypotrichose congénitale des cils --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hypotrichose congénitale des cils | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  379. hypotrichose congénitale simple --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hypotrichose congénitale simple | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  380. hypotrichose héréditaire de Marie Unna --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hypotrichose héréditaire de Marie Unna | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  381. hypotrichose, atrophodermie folliculaire et épithéliomatose --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=hypotrichose, atrophodermie folliculaire et épithéliomatose | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
  382. syndrome d'hypermobilité articulaire --- r_associated #0: 5 --> en:c-cell hyperplasia
    n1=syndrome d'hypermobilité articulaire | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr